BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29722334)

  • 21. Impact of combination therapy and early de-escalation on outcome of ventilator-associated pneumonia caused by Pseudomonas aeruginosa.
    Deconinck L; Meybeck A; Patoz P; Van Grunderbeeck N; Boussekey N; Chiche A; Delannoy PY; Georges H; Leroy O
    Infect Dis (Lond); 2017 May; 49(5):396-404. PubMed ID: 28092204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early antibiotic discontinuation in patients with clinically suspected ventilator-associated pneumonia and negative quantitative bronchoscopy cultures.
    Raman K; Nailor MD; Nicolau DP; Aslanzadeh J; Nadeau M; Kuti JL
    Crit Care Med; 2013 Jul; 41(7):1656-63. PubMed ID: 23528805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between a silver-coated endotracheal tube and reduced mortality in patients with ventilator-associated pneumonia.
    Afessa B; Shorr AF; Anzueto AR; Craven DE; Schinner R; Kollef MH
    Chest; 2010 May; 137(5):1015-21. PubMed ID: 20038737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the bacterial etiology of early-onset and late-onset ventilator-associated pneumonia in subjects enrolled in 2 large clinical studies.
    Restrepo MI; Peterson J; Fernandez JF; Qin Z; Fisher AC; Nicholson SC
    Respir Care; 2013 Jul; 58(7):1220-5. PubMed ID: 23307825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review.
    Lorente L; Jiménez A; Palmero S; Jiménez JJ; Iribarren JL; Santana M; Martín MM; Mora ML
    Clin Ther; 2007 Nov; 29(11):2433-9. PubMed ID: 18158083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia.
    Czosnowski QA; Wood GC; Magnotti LJ; Croce MA; Swanson JM; Boucher BA; Fabian TC
    Pharmacotherapy; 2009 Sep; 29(9):1054-60. PubMed ID: 19698010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors of multidrug-resistant bacteria infection in patients with ventilator-associated pneumonia: A systematic review and meta-analysis.
    Hu JN; Hu SQ; Li ZL; Bao C; Liu Q; Liu C; Xu SY
    J Infect Chemother; 2023 Oct; 29(10):942-947. PubMed ID: 37321291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. De-escalation therapy in ventilator-associated pneumonia.
    Niederman MS
    Curr Opin Crit Care; 2006 Oct; 12(5):452-7. PubMed ID: 16943725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for relapse of ventilator-associated pneumonia in trauma patients.
    Rangel EL; Butler KL; Johannigman JA; Tsuei BJ; Solomkin JS
    J Trauma; 2009 Jul; 67(1):91-5; discussion 95-6. PubMed ID: 19590315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteremia and ventilator-associated pneumonia: a marker for contemporaneous extra-pulmonic infection.
    Kunac A; Sifri ZC; Mohr AM; Horng H; Lavery RF; Livingston DH
    Surg Infect (Larchmt); 2014 Apr; 15(2):77-83. PubMed ID: 24192306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia.
    Combes A; Luyt CE; Fagon JY; Wolff M; Trouillet JL; Chastre J
    Crit Care Med; 2007 Jan; 35(1):146-54. PubMed ID: 17080004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aerosolized Amikacin as Adjunctive Therapy of Ventilator-associated Pneumonia Caused by Multidrug-resistant Gram-negative Bacteria: A Single-center Randomized Controlled Trial.
    Liu C; Zhang YT; Peng ZY; Zhou Q; Hu B; Zhou H; Li JG
    Chin Med J (Engl); 2017 May; 130(10):1196-1201. PubMed ID: 28485320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis.
    De Pascale G; De Maio F; Carelli S; De Angelis G; Cacaci M; Montini L; Bello G; Cutuli SL; Pintaudi G; Tanzarella ES; Xhemalaj R; Grieco DL; Tumbarello M; Sanguinetti M; Posteraro B; Antonelli M
    Crit Care; 2021 Jun; 25(1):197. PubMed ID: 34099016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of antimicrobial de-escalation for culture-negative severe pneumonia.
    Byoung Soo K; Sang Ho C; Younsuck K; Jin-Won H; Sang-Bum H; Chae-Man L
    J Crit Care; 2019 Dec; 54():14-19. PubMed ID: 31319347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GRam stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) trial: rationale and study protocol for a randomised controlled trial.
    Yoshimura J; Yamakawa K; Kinoshita T; Ohta Y; Morimoto T
    Trials; 2018 Nov; 19(1):614. PubMed ID: 30409160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of Treatment Failure Following De-escalation to a Fluoroquinolone in Culture-Negative Nosocomial Pneumonia.
    Bultas AC; Bery AI; Deal EN; Hartmann AP; Richter SK; Call WB
    Ann Pharmacother; 2019 Dec; 53(12):1207-1213. PubMed ID: 31347400
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of post-pyloric feeding by spiral nasoenteric tubes on ventilator-associated pneumonia in neurocritical care patients: a retrospective analysis of three clinical randomized controlled trials].
    Ouyang X; He Z; Hu B; Chen C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Aug; 31(8):967-971. PubMed ID: 31537221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Performance of clinical pulmonary infection score induces the duration and defined daily doses of antibiotics in patients with bacterial severe pneumonia in intensive care unit].
    Shen F; Wu Y; Wang Y; Li W; Liu B; Qian H; Yang H; Yang G; Li X; Zheng X; Wu Y; Xie L; Gao D; Li L; Liu M
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 May; 31(5):556-561. PubMed ID: 31198139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ventilator-associated pneumonia: overdiagnosis and treatment are common in medical and surgical intensive care units.
    Nussenblatt V; Avdic E; Berenholtz S; Daugherty E; Hadhazy E; Lipsett PA; Maragakis LL; Perl TM; Speck K; Swoboda SM; Ziai W; Cosgrove SE
    Infect Control Hosp Epidemiol; 2014 Mar; 35(3):278-84. PubMed ID: 24521594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of Antibiotic De-escalation by Spectrum Score in Patients With Nosocomial Pneumonia: A Single-Center, Retrospective Cohort Study.
    Ilges D; Ritchie DJ; Krekel T; Neuner EA; Hampton N; Kollef MH; Micek S
    Open Forum Infect Dis; 2021 Nov; 8(11):ofab508. PubMed ID: 34805436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.